These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 35303057)

  • 1. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
    Zuidhof HR; Calkhoven CF
    Cancer Res; 2022 Jun; 82(12):2201-2212. PubMed ID: 35303057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.
    Annapoorna PK; Iyer H; Parnaik T; Narasimhan H; Bhattacharya A; Kumar A
    Neuroscience; 2019 Oct; 418():15-24. PubMed ID: 31442565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 6. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FTO in cancer: functions, molecular mechanisms, and therapeutic implications.
    Li Y; Su R; Deng X; Chen Y; Chen J
    Trends Cancer; 2022 Jul; 8(7):598-614. PubMed ID: 35346615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
    Meyer KD; Jaffrey SR
    Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms.
    Azzam SK; Alsafar H; Sajini AA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Inhibitors Targeting the Oncogenic m
    Huang Y; Xia W; Dong Z; Yang CG
    Acc Chem Res; 2023 Nov; 56(21):3010-3022. PubMed ID: 37889223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Roles of FTO in Neuropsychiatric Disorders.
    Chang R; Huang Z; Zhao S; Zou J; Li Y; Tan S
    Biomed Res Int; 2022; 2022():2677312. PubMed ID: 35528183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.
    Relier S; Rivals E; David A
    RNA Biol; 2022; 19(1):132-142. PubMed ID: 35067178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide inhibits FTO demethylase activity to regulate N
    Kuschman HP; Palczewski MB; Hoffman B; Menhart M; Wang X; Glynn S; Islam ABMMK; Benevolenskaya EV; Thomas DD
    Redox Biol; 2023 Nov; 67():102928. PubMed ID: 37866163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic transcriptomic m
    Yang Y; Hsu PJ; Chen YS; Yang YG
    Cell Res; 2018 Jun; 28(6):616-624. PubMed ID: 29789545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Liu J; Ren D; Du Z; Wang H; Zhang H; Jin Y
    Biochem Biophys Res Commun; 2018 Aug; 502(4):456-464. PubMed ID: 29842885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 Regulates N
    Liu X; Liu J; Xiao W; Zeng Q; Bo H; Zhu Y; Gong L; He D; Xing X; Li R; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Guo F; Xu C; Chen X; Wang X; Wang F; Wang Q; Cao K
    Hepatology; 2020 Dec; 72(6):2029-2050. PubMed ID: 32154934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
    You Y; Fu Y; Huang M; Shen D; Zhao B; Liu H; Zheng Y; Huang L
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.